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Objectil'es. This study was performed to obtain better under-
standing of the long· term clinical efficacy of directional coronary 
atherectomy. 
Background. Although this procedure yields fa\'orable acute 
results, its acceptance has been limited by the perception that late 
results (that is, freedom from restenosis) are no better than those 
of conwntional angioplasty. 
Methods. A total of 225 atherectomies performed in 190 patients 
between August 1988 and July 1991 were examined. Minimal lumen 
diameter of the treated segments was measured on angiograms 
obtained before, after and 6 months after intenention. 
Results. Although most lesions (97%) had one or more char-
acteristics predicth'e of unfayorable short· or long-term results 
after com'entional angioplasty, atherectomy was successful in 205 
lesions (91%) with a mean residual stenosis of 7 ± 16%. After 
subsequent balloon angioplasty in 16 unsuccessful atherectomy 
attempts, procedural success was 98%. There were no deaths or Q 
waye myocardial infarctions, and one patient (0.5 %) underwent 
emergency bypass surgery. 
Directional coronary atherectomy was developed in an at· 
tempt to overcome some of the limitations of conventional 
balloon angioplasty. In theory, controlled excision of athero-
sclerotic tissue by directional coronary atherectomy might 
create a larger lumen without the dissections, flaps or 
thrombus common after angioplasty. This procedure should 
reduce the incidence of abrupt vessel closure, allow the 
treatment of complex lesions that might be difficult to 
approach by conventional angioplasty and leave a smoother 
lumen less conducive to platelet aggregation, thereby blunt· 
ing subsequent intimal hyperplasia and reducing the inci-
dence of restenosis (1-3). 
The reported acute success and complication rates of direc-
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Six-month angiographic follow-up was obtained in 77% of the 
eligible patients. The onrall angiographic restenosis rate was 
32 %. Predictors of a lower restenosis rate included a postproce-
dure lumen diameter >3 mm (24% ys. 39%, p = 0.047), serum 
cholesterol ::;200 mgldl (18% \'s. 40%, p = 0.018) and recent 
myocardial infarction (16% \'s. 37%, p = 0.034). 
Life-table analysis showed a 2% mortality rate and a 26% 
incidence of other events (myocardial infarction, repeat re\'ascular· 
ization) within the 1st year. The annual 5% mortality rate and 7% 
incidence of other events during years 2 and 3 were related in large 
part to the existence or progression of disease at other locations. 
Conclusions. Six-month angiographic follow-up of patients 
who underwent directional coronary atherectomy during the 1st 
3 years of our experience shows an owrall restenosis rate of 32%, 
with lower rates in patients with a postatherectomy lumen diam-
eter ~3 mm, cholesterolleyel ::;200 mgldl or a recent myocardial 
infarction. Few if any e\'ents relating to the site of atherectomy 
denloped after the 1st year of follow-up. 
(J Am Call CardioI1992;20:1l01-10) 
tional coronary atherectomy have been favorable (2-7), partic-
ularly when certain adverse demographic, vessel and lesion 
characteristics (for example, calcification, diffuse disease, an-
gulation and vessel tortuosity) are absent (8-10). However, the 
overall acceptance of the procedure has been limited by the 
perception that late results are no better than those of conven-
tional angioplasty; that is, their restenosis rates are compara-
ble. Although several thousand atherectomy procedures have 
been performed in the coronary circulation, little has been 
published on how the long-term clinical and angiographic 
efficacy of directional coronary atherectomy is affected by 
various clinical, angiographic and histologic factors. To the 
extent that the ultimate role of atherectomy will be influenced 
by a better understanding of what predicts long-term efficacy, 
we undertook the current evaluation of 225 consecutive direc-
tional coronary atherectomy procedures performed at Boston's 
Beth Israel Hospital. 
Methods 
Patient group. Between August 5,1988 and July 31,1991, 
we performed directional coronary atherectomy in 225 Ie-
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sions (190 patients); the procedure accounted for 9% of the 
2,146 interventional procedures performed during that pe-
riod. All patients had objective evidence of myocardial 
ischemia (either by exercise treadmill testing or by sponta-
neous rest ischemia) and had a :::70% stenosis believed to be 
accessible with the atherectomy device. Patients were ex-
cluded from the study if their diseased vessel was <2.5 mm 
in diameter, severely tortuous or heavily calcified. 
Atherectomy procedure. All procedures were performed 
with the Simpson AtheroCath (Devices for Vascular Inter-
vention). The device and details of the procedure have been 
described previously (3,4, II). Premedication with aspirin 
(325 mg/day ) and dipyridamole (200 mg/day), was started 
24 h before the procedure in all patients and continued 
indefinitely. A 10,000 U bolus of heparin was given after 
insertion of the arterial sheath (10 or II F) and supplemented 
as needed to maintain the activated clotting time at >300 s. 
The atherectomy device was positioned across the lesion 
over a 0.014-in. (0.036 cm) guide wire advanced through a 
9.5, 10 or IIF guiding catheter (Devices for Vascular Inter-
vention). The number of cuts performed, maximal balloon 
inflation pressures and the final device size were determined 
by the reference vessel size and residual stenosis after 
atherectomy. Generally, a 6F device (3.5-mm working diam-
eter) was used when the reference vessel diameter was 
<3.0 mm. A 7F device (4-mm working diameter) was used 
when the reference diameter was :::3 mm or when a signifi-
cant residual stenosis resulted after the use of higher balloon 
inflation pressures (40 to 60 psi) with a 6F device. A 7F graft 
device (4.5-mm working diameter) was used for vessels with 
a diameter :::4 mm. Although specimens were not routinely 
weighed during our most recent procedures, our previous 
experience (4) indicated that a mean of 11.6 ± 6 specimens 
(weighing an average of 18.5 mg/lesion) were removed. Our 
approach to tissue removal has not changed since this earlier 
report. Pre dilation with a conventional angioplasty balloon 
was performed only when difficulty crossing the lesion 
occurred or was anticipated because of lesion morphology. 
The use of conventional angioplasty after successful 
atherectomy was reserved for an unacceptable residual 
stenosis, mild to moderate dissections or the rescue of 
compromised side branches. Sheaths were typically re-
moved on the same day as the procedure once the activated 
clotting time was <180 s. 
Successful directional coronary atherectomy was defined 
as tissue removal, a residual diameter stenosis <50% with-
out having to use conventional balloon angioplasty after 
atherectomy and the absence of a major complication (emer-
gency coronary artery bypass graft surgery, Q wave myo-
cardial infarction or death). Procedural success was defined 
as a residual diameter stenosis <50% (including that ob-
tained by the use of conventional angioplasty balloon after 
unsuccessful atherectomy) without a major complication. 
Serum creatine kinase (CK) levels and 12-lead electrocardio-
grams (ECGs) were obtained on all patients after the proce-
dure and the next day. There were no Q wave myocardial 
JACC Vol. 20, No.5 
November I, 1992:1101-10 
infarctions, but non-Q wave myocardial infarction was 
diagnosed when the postprocedure CK level was >200 IUlliter 
with positive MB isoforms. All atherectomy procedures 
were performed under a protocol approved by the Com-
mittee on Clinical Investigation at Boston's Beth Israel 
Hospital. 
Angiographic analysis. Digital calipers (Fowler Ultra-Cal 
II) were used to measure the minimal lumen diameter from 
magnified images obtained in the single most stenotic view 
before and after directional coronary atherectomy: the di-
ameters of the proximal and distal reference segments were 
averaged to yield a mean reference diameter. A 9F conven-
tional angioplasty guiding catheter was used as the reference 
object. As described previously (12), the aClite gain was 
defined as the increase in diameter of the treated segment 
from before to immediately after atherectomy, and late loss 
was defined as the subsequent decrease in diameter of the 
treated segment by the time of follow-up angiography. The 
overall net gain was therefore the difference between the 
acute gain and late loss. 
Tissue analysis. Directional coronary atherectomy speci-
mens were fixed in 10% buffered formalin and embedded in 
paraffin, and 6-J..tm sections were stained with hematoxylin-
eosin, Masson's trichrome and elastic van Gieson stains. 
Standard light microscopy was performed by one of us 
(S.J.S.) with evaluation of specimens for the presence of 
atherosclerotic plaque, intimal hyperplasia, media, adventi-
tia and thrombus. 
Follow-up. Successfully treated patients were advised to 
have serial exercise testing at I, 3 and 6 months after 
directional coronary atherectomy. Coronary angiography 
was performed at 6 months unless earlier angiography was 
clinically indicated. Angiographic studies that did not show 
restenosis (diameter stenosis :::50%) were included only if 
they were performed >4 months after the initial procedure. 
Clinical follow-up was also obtained by clinic visit or tele-
phone contact. 
Statistics. Data were expressed as the mean value ± 1 
SD. The Student t test was used for comparison of data 
between subgroups. The association of restenosis with cat-
egoric and continuous variables was analyzed by using 
chi-square and logistic regression analysis, respectively. 
Event-free survival was determined by Kaplan-Meier tech-
niques and displayed as a standard survival curve. 
Results 
Patient group. Our study group was congruent with that 
seen in most interventional catheterization laboratories, 
including the high proportion of patients with unstable 
angina (64%) or recent «6 weeks) myocardial infarction 
(27%) (Table I). Most directional coronary atherectomy 
procedures were performed in the left anterior descending 
coronary artery (63%) (Table 2). Of 35 saphenous vein graft 
lesions, 14 were located at the aorto-ostial junction. Most 
lesions were new, but 32% of atherectomy procedures were 
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Table I. Demographics in 190 Patients 
Age (yr) (mean:!: SO) 
Men 
History of smoking 
Hypertension 
Diabetes mellitus 
Family history of CAD 
Serum cholesterol >200 mg!dl 
Unstable angina 
Multivessel CAD 
Two-vessel 
Three-vessel 
Congestive heart failure 
Recent' myocardial infarction 
Remote myocardial infarction 
No. 
58 ± 12 (range 34 to 87) 
150 
98 
91 
40 
95 
114 
122 
93 
43 
50 
II 
56 
42 
'<6 weeks. CAD = coronary artery disease. 
% 
79 
51 
48 
21 
50 
60 
64 
49 
23 
26 
6 
27 
22 
performed in restenotic lesions that had developed after 
prior conventional angioplasty, atherectomy or laser balloon 
angioplasty. The majority (97%) of lesions were considered 
unfavorable for conventional angioplasty because of eccen-
tricity. ostial location or calcification. alone or in combina-
tion. 
Immediate results. Directional coronary atherectomy 
was successful in 205 (91%) of 225 lesions (Table 3). Suc-
cessful conventional angioplasty was performed in 16 addi-
tionallesions after failed atherectomy, bringing the overall 
procedural success to 221 (98%) of 225 lesions. Successful 
directional coronary atherectomy was less likely in lesions in 
Table 2. Angiographic Characteristics of 225 Lesions 
No. 
Vessel 
Native 190 
LAD 143 
RCA 22 
LCx 21 
LM 4 
SVG 35 
Prior treatment 
Native arteries 
New lesion 126/190 
Prior restenosis 64/190 
SVG 
New lesion 27/35 
Prior restenosis 8/35 
Overall 
Prior restenosis 7'11225 
Morphology 
Eccentric 165 
Ostial 48 
Calcified 38 
2:1 of above 218 
% 
84 
63 
10 
9 
2 
16 
66 
34 
77 
23 
32 
73 
21 
17 
97 
LAD = left anterior descending coronary artery; LCx = left circumflex 
artery; LM = left main coronary artery; RCA = right coronary artery; 
SVG = saphenous vein graft. 
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Table 3. Procedural Data 
No. % 
DCA success' 205/225 91 
Native arteries 1721190 91 
LAD 134/143 94 
RCA 17122 77 
LCx 19/21 90 
LM 214 SO 
SVG 33/35 94 
Procedural successt 2211225 98 
Adjunctive PTCA 
Pre DCA 27 13 
Post DCA 22 II 
Device size (working diameter) 
SF (2.7 mm) 6 3 
6F (3 mm) 112 56 
7F (4 mm) 75 37 
7F (4.5 mm) 7 4 
Pre Post 
Reference vessel diameter (mm) 
Overall 3.21 :!: 0.74 
Native arteries 
LAD 3.00 ± 0.60 
LCx 2.99 :!: 0.54 
RCA 3.81 :!: 0.74 
SVG 3.80 ± 0.83 
Lumen diameter 
Overall 0.71 ± 0.39 2.96:!: 0.62 
Native arteries 
LAD 0.68 ± 0.33 2.84 :!: 0.56 
LCx 0.65 :!: 0.35 2.76 :!: 0.50 
RCA 0.67 :!: 0.31 3.16 ± 0.66 
SVG 0.86:!: 0.60 3.47 ± 0.58 
Stenosis 
Overall 78 ± 11% 7:!: 16% 
'Success defined as retrieval of tissue, <50% residual stenosis without a 
major complication (death, Q wave myocardial infarction or emergency 
coronary bypass surgery). tlncluding conventional angioplasty. Unless oth-
erwise indicated, values are mean values ± 1 SO. DCA = directional coronary 
atherectomy; Post = after; Pre = before; PTCA = percutaneous transluminal 
coronary angioplasty; other abbreviations as in Table 2. 
the right coronary artery (77%) or the left main coronary 
artery (50%) than for lesions in the left anterior descending 
artery (94%). Successful atherectomy resulted in an increase 
in mean lumen diameter from 0.71 :!: 0.39 mm to 2.96 :!: 
0.62 mm, with a residual stenosis 00 :!: 16%. Supplemental 
conventional angioplasty was used infrequently (before in 27 
[13%] and after in 22 [11%] of 225 atherectomy procedures). 
Complications. Major complications (emergency coro-
nary artery bypass grafting, Q wave myocardial infarction or 
death) were infrequent (0.5%) (Table 4). Elective coronary 
artery bypass grafting (defined as surgery between 24 h after 
directional coronary atherectomy and hospital discharge) 
was needed in 2.6% of patients, typically to treat unsuccess-
ful but uncomplicated atherectomy attempts. Transient 
abrupt vessel closure of the treated segment occurred in 
1104 FISHMAN ET AL. 
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Table 4. Complications 
No. % 
Major 
Death (in·hospital) 0 0 
Qwave MI 0 0 
Emergency CABG 0.5 
Other 
Nonemergency CABG' 5 2.6 
Transient abrupt closure reversed by PTCA 
Treated segment 6 3.2 
Side branch 7 3.7 
Postprocedure CK >200 IUlliter 14 7.4 
Vascular 
Transfusion 5 2.6 
Surgical repair 7 3.7 
Vessel perforationt 0.5 
Stroke 0.5 
Wound infection 0.5 
Ventricular tachycardia 0.5 
'Includes that performed after an unsuccessful but uncomplicated 
atherectomy attempt. tTransient dye extravasation without clinical sequelae. 
CABG = coronary artery bypass surgery; CK = creatine kinase; MI = 
myocardial infarction; PTCA = percutaneous transluminal coronary angio· 
pia sty. 
3.2% of atherectomy attempts, but was invariably managed 
successfully by conventional or laser balloon angioplasty. 
Abrupt closure of involved side branches occurred in 3.7% 
of atherectomy attempts but was also successfully treated 
with conventional angioplasty in all cases. Vessel perfora-
tion (transient localized dye extravasation) was seen in one 
vein graft lesion, without clinical sequelae. Non-Q wave 
myocardial infarction (defined here as postprocedure CK 
>200 IUniter) occurred in 7.4% of patients. 
Histology (Table 5). Recovery of deep wall components 
(media [66%]/adventitia [28%]) was frequent. There was no 
association between retrieval of deep wall components and 
device size, reference artery diameter or procedural compli-
cations. However, the mean reference vessel diameter when 
adventitia was recovered (3.0 ± 0.71 mm) did tend to be 
slightly smaller than when it was not recovered (3.24 ± 
0.79 mm). One patient showed evidence of local coronary 
aneurysm at the time of 6-month angiography, without 
further clinical sequelae or need for repeat revascularization. 
In this patient, directional coronary atherectomy had been 
successfully performed for a lesion in a circumflex . lesion 
with a 6F device at a maximal balloon inflation pressure of 
30 psi yielding both media and adventitia. 
Intimal hyperplasia was seen in 42% of new native 
lesions, compared with 91% of rest en otic native lesions (p = 
0.(05). Thrombus was seen more frequently (63% vs. 37%) 
in saphenous vein graft lesions compared with native le-
sions. 
Late results. Six-month angiographic follow-up was ob-
tained in 77% of the patients studied ;::::4 months after 
directional coronary atherectomy and showed a 32% overall 
angiographic restenosis rate (defined as diameter stenosis 
JACC Vol. 20, No.5 
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Table 5. Histologic Features of 188 Specimens 
No. % No. % 
All lesions 
Atherosclerotic plaque 178 95 
Intimal hyperplasia 107 57 
Media 124 66 
Adventitia 52 28 
Thrombus 77 41 
Native lesions New (n = \05) Prior restenosis (n = 56) 
Atherosclerotic plaque 103 98 53 95 
Intimal hyperplasia 44 42 51 91' 
Media 72 69 35 63 
Adventitia 36 34 11 20 
Thrombus 39 37 21 38 
SVG lesions New (n = 19) Prior restenosis (n = 8) 
Atherosclerotic plaque 15 79 7 88 
Intimal hyperplasia 7 37 5 63 
Media 11 58 6 75 
Adventitia 2 11 3 38 
Thrombus 10 53 7 88 
'p = 0.005, prior restenosis versus new lesions. SVG = saphenous vein 
graft. 
;::::50%) (Table 6). There was a trend toward a lower resten-
osis rate for lesions in the right coronary artery (25%) or 
saphenous vein graft (28%) than for lesions in the left 
anterior descending coronary artery (38%, p = NS). Reste-
nosis rates tended to be higher (39% vs. 28%, p = NS) for 
lesions with prior restenosis versus new lesions. 
Insight into these differences in restenosis may be ob-
tained by analyzing the corresponding differences in aClite 
gain (increase in diameter of the treated segment from before 
to immediately after directional coronary atherectomy), late 
loss (decrease in diameter of the treated segment from 
immediately after atherectomy to the time of follow-up 
angiography) and net gain (difference between the acute gain 
and late loss) (Table 7). The overall acute gain was 
2.25 ± 0.64 mm with a late loss of 1.07 ± 0.92 mm, yielding 
a net gain of 1.17 mm. Net gain was largest for right coronary 
artery, left circumflex coronary artery and saphenous vein 
graft lesions, corresponding to the lower observed restenosis 
rates for lesions at these sites compared with those for 
lesions in the left anterior descending artery. Directional 
coronary atherectomy of new lesions produced both greater 
acute gain and less late loss, yielding a better net gain and a 
trend toward a lower restenosis rate compared with that of 
lesions with prior restenosis. 
Predictors of restenosis. A cholesterol level <200 mg/dl at 
the time of directional coronary atherectomy, recent myo-
cardial infarction «6 weeks) and postatherectomy lumen 
diameter;::::3 mm were each univariable predictors ofa lower 
incidence of restenosis (Table 8). There was no adverse 
influence of recovery of media or adventitia on subsequent 
restenosis, with a trend toward a lower incidence of resten-
osis in lesions from which adventitia had been recovered. 
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Table 6. Late Results: Angiographic Follow-Up 
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Patients eligible for 6-month angiographic follow·up (no.) 159 
Patients who had 6·month angiographic follow·up (no; %) 122; 77 
Average time to follow·up (days) 179 ± 57 
Lumen Diameter Restenosis· (stenosis 2: 50%) 
(mm) % Stenosis No. % 
Overall 1.89 :!: 0.98 38:!: 29 39/122 32 
Vessel location 
Native 
LAD 1.70:!: 0.94 41 :!: 30 30m 38 
LCx 2.02 :!: 0.54 29:!: 16 1113 8 
RCA 2.35 :!: 0.94 35 :!: 22 3/12 25 
SVG 2.36:!: 1.19 33 :!: 35 5118 28 
Prior treatment 
New lesion 2.09:!: 0.96 34 :!: 28 21n6 28 
Prior restenosis 1.57 :!: 0.92 45 :!: 29 18146 39 
Histologic findingst 
Media 1.88 :!: 0.99 38 :!: 29 23m 32 
Adventitia 2.05 :!: 0.93 30:!: 27 8134 24 
No deep wall components 1.95 :!: 1.00 37 :!: 29 16153 30 
*(2:50% lumen diameter narrowing). tThe denominator sum is > 122 as several specimens containing adventitia 
also had media. Unless otherwise indicated, values are mean values:!: I SO. Abbreviations as in Table 2. 
If these follow-up data are expressed as cumulative 
frequency distributions (as previously described by Kuntz et 
al. [12]), any follow-up percent stenosis (for example, 50%) 
can be selected to determine the corresponding restenosis 
rate according to that threshold. Lesions whose postatherec-
tomy lumen diameter was <3 mm (Fig. 1) thus had a 
restenosis rate of 39%, whereas lesions whose postatherec-
Table 7. Acute GainlLate Loss 
Acute Gain 
(mm) 
Overall 2.25 :!: 0.64 
Native arteries 
LAD 2.16:!: 0.45 
LCx 2.09 ± 0.45 
RCA 2.64 :!: 0.46 
SVG 2.67 :!: 0.82 
New lesion 2.41 :!: 0.64 
Prior restenosis 2.08 :!: 0.58 
Recovery of 
Media 2.23 :!: 0.59 
Adventitia 2.15 :!: 0.64 
No deep wall components 2.37 :!: 0.67 
Lumen diameter post DCA 
2:3mm 2.74 :!: 0.57 
<3mm 1.91 :!: 0.42 
Serum cholesterol 
>200 mgldl 2.32 :!: 0.67 
!S200 mgldl 2.25 :!: 0.61 
Recent MI 
+ 2.34 :!: 0.61 
2.27 :!: 0.66 
tomy lumen diameter was ;;::3 mm had a restenosis rate of 
24% (p = 0.047), by using a ;;::50% stenosis definition. 
Although there was an increase in the late loss for lesions 
with a postatherectomy lumen diameter ;;::3 mm (Table 7), 
net gain remained larger because of the even greater acute 
gain. Lesions in patients with a serum cholesterol level 
>200 mg/dl (Fig. 2) had a restenosis rate of 40%; whereas 
Late Loss Net Gain Restenosis 
(mm) (mm) Rate (%) 
1.07 :!: 0.92 1.20 :!: 0.97 32 
1.12 :!: 0.91 1.00 :!: 0.90 38 
0.60:!: 0.61 1.45 :!: 0.60 8 
1.07 :!: 0.84 1.69 :!: 1.15 25 
1.20 :!: 1.21 1.64 :!: 1.16 28 
1.02 :!: 0.96 1.40 :!: 0.94 28 
1.15 :!: 0.89 0.9O:!: 0.97 39 
1.05 :!: 0.89 1.18 :!: 0.95 32 
0.84 :!: 0.96 1.31 :!: 0.91 24 
1.01 :!: 1.00 1.31 :!: 1.02 30 
1.25 :!: 0.98 1.50 :!: 1.01 24 
0.93 :!: 0.89 0.96 :!: 0.88 39 
1.21 :!: 0.97 1.10 :!: 1.06 40 
0.88 :!: 0.86 1.36:!: 0.82 18 
0.83 :!: 0.91 1.49:!: 0.81 16 
1.15 :!: 0.94 1.11 :!: 1.01 37 
Values are mean values:!: I SO. - = Absent; + = Present. Other abbreviations as in Tables 2 to 4. 
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Table 8. Predictors of Restenosis 
Risk Ratio p Value 
Demographic 
Cholesterol level >200 mg/dl 2.22 0.0\8 
History of smoking NS 
Diabetes mellitus NS 
Family history of CAD NS 
Congestive heart failure NS 
Unstable angina NS 
Recent MI «6 weeks) 0.28 0.034 
Remote MI (>6 weeks) NS 
Angiographic 
Eccentric NS 
Ostial NS 
Calcified NS 
Prior restenosis NS 
Length (continuous variable) NS 
Length 2:10 mm NS 
Post-DCA dissection NS 
Post-DCA intimal flap NS 
Procedural 
Post lumen diameter 2:3 mm* 0.63 0.047 
Device size NS 
PICA pre DCA NS 
PICA post DCA NS 
Histologic 
Atherosclerotic plaque NS 
Intimal hyperplasia NS 
Media NS 
Adventitia 0.63 0.176 
Thrombus NS 
*2:3 mm versus <3 mm. Abbreviations as in Tables I, 3, and 4. 
lesions in patients with a cholesterol level :5200 mg/dl had a 
restenosis rate of 18% (p = 0.018). Reference vessel size and 
acute gain were similar for these two groups, but patients 
with a cholesterol level >200 md/gl had more late loss (1.21 
Figure 1. Cumulative distribution of percent stenosis at follow-up 
based on the postprocedure lumen diameter. Angiographic resteno-
sis (for example, diameter stenosis ;:::50% at follow-up) is signifi-
cantly lower for lesions whose postprocedure lumen diameter was 
;:::3 mm. Post-DCA = after directional coronary atherectomy. 
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Cholesterol $200 m~/dl 
Cholesterol >200 mg/dl 
40% } p=0.018 
40 60 80 100 
% of Patients (Cumulative Rank) 
Figure 2. Cumulative distribution of percent stenosis at follow-up 
based on serum cholesterol level at the time of procedure. Angio-
graphic restenosis (for example, diameter stenosis ;:::50% at follow-
up) is significantly lower when serum cholesterol is $200 mg/dl. 
vs. 0.88 mm), which translated into less net gain and a higher 
observed restenosis rate (Table 7). 
Long-term clinical follow-up. Patients were contacted by 
telephone or clinic visit at 6 weeks, 3 months, 6 months and 
then annually by the investigators. Follow-up data were 
available for 188 (99%) of 190 patients, at an average 
follow-up interval of 18.2 ± 11.9 months. This analysis 
included all patients, even if the index procedure was 
unsuccessful. Event-free survival was defined as absence of 
death, myocardial infarction or repeat revascularization (by 
percutaneous transluminal coronary angioplasty [PTCA] or 
coronary artery bypass grafting). Table 9 and Figure 3 show 
initial and long-term freedom from events as assessed by 
Kaplan-Meier analysis. In terms of absolute events there 
was a 2% mortality rate in the 1st year with a 26% incidence 
of other events (myocardial infarction 1%, repeat angio-
pia sty 17%, coronary artery bypass grafting 12%). Over the 
next 2 years, there was an annual 5% mortality rate and 7% 
incidence of other events (myocardial infarction 2%, repeat 
angioplasty 3%, coronary artery bypass grafting 2%). During 
the follow-up period, 10 patients died, 4 had a myocardial 
infarction, 32 had repeat revascularization by coronary 
angioplasty and 22 by coronary artery bypass grafting. All 
revascularization procedures were included as events, even 
if they were performed for lesions other than one at the site 
Table 9. Long-Term Clinical Follow-Up 
FolIow-Up (months) 
6 12 24 36 
Survival (%) 98 98 95 87 
Event-free survival (%) 79 74 68 59 
Freedom from MI (%) 99 99 99 95 
Freedom from PICA (%) 86 83 80 76 
Freedom from CABG (%) 92 88 86 83 
Abbreviations as in Table 4. 
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Figure 3. Freedom from death, death or myocardial infarc-
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of the original atherectomy. Thus, five patients had angio-
plasty performed and three patients had coronary artery 
bypass grafting performed on the vessel not treated with 
atherectomy, despite a patent atherectomy-treated vessel. 
All late deaths were also included, even though two of the 
late deaths were of noncardiac causes (pneumonia in one 
patient, lung cancer in the other). 
Discussion 
Since Gruentzig's pioneering work in the late 1970s 
(13-16), the technology and techniques of conventional 
angioplasty have been refined progressively, allowing 
broader application, improved success and fewer complica-
tions (15). Even so, problems continue to occur with con-
ventional angioplasty because of I) failure to cross a stenosis 
or occlusion, 2) failure to dilate a rigid or eccentric elastic 
lesion, 3) abrupt vessel closure~ and 4) restenosis (17). 
Directional coronary atherectomy was developed in an at-
tempt to overcome some of these limitations. 
Immediate Results 
Several reports (3-10,18-20) have demonstrated that di-
rectional coronary atherectomy can be performed safely and 
effectively, despite its frequent use in lesions generally 
considered to be unfavorable for conventional angioplasty. 
Our pattern of using it in 9% of coronary revascularization 
procedures (particularly concentrating on such suboptimal 
angioplasty lesions) is similar to the 11% utilization rate 
reported during 1992 at centers having trained operators 
(Devices for Vascular Intervention, personal communica-
tion). The 91% rate of successful directional coronary 
atherectomy and 98% overall procedural success rate (in-
cluding subsequent use of conventional angioplasty) re-
ported in our series are consistent with earlier reports 
(3,4,7-10,18). When the procedure was unsuccessful, the 
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most common cause of failure was inability to advance the 
rigid atherectomy device through a calcified or tortuous 
vessel segment. The incidence of major complications 
(emergency coronary artery bypass grafting, Q wave myo-
cardial infarction or death) was low (0.5%), despite the 
presence of many clinical and angiographic predictors of 
adverse outcome (lesions that are new, in the left main or 
right coronary artery, eccentric,;:::10 mm in length, calcified, 
aorta-ostial, angulated, tortuous or bifurcated, as well as 
those containing dissections, ulcerations or thrombus) (8-
10). Other complication rates including abrupt vessel clo-
sure, elevated plasma CK levels and late coronary aneurysm 
formation were comparable with those seen after conven-
tional angioplasty (15,21,22). 
Our 7% average residual stenosis after directional coro-
nary atherectomy reflects our philosophy that obtaining low 
restenosis rates with a new device is predicated on obtaining 
excellent initial results (12). In that regard, the 2.25-mm 
acute gain that we observed with atherectomy was greater 
than that seen after conventional angioplasty (12,23,24). 
Popma et al. (10) recently also reported better immediate 
results with use of larger atherectomy devices, but worse 
acute results in restenotic lesions, diffuse proximal disease, 
lesion length ;:::10 mm and calcified lesions. 
These excellent acute results were generally obtained 
without adjunctive conventional angioplasty. Predilation 
(13% of cases) was reserved for tight new, calcified or 
aorta-ostial lesions and was not used routinely because of 
concern that predilation might make subsequent tissue re-
moval more difficult. This result is consistent with the recent 
observations of the New Approaches for Coronary Interven-
tion Registry (25). Dilation after successful directional cor-
onary atherectomy (11% of cases) was used only when a 
significant residual stenosis remained after use of the appro-
priate size device and higher (40 to 60 psi) balloon inflation 
pressures, to treat local dissection or to rescue side branches 
compromised during the procedure. However, the infre-
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quent use of adjunctive coronary angioplasty does not imply 
that all improvement in lumen diameter was due to tissue 
removal: our prior studies (4,26) showed that up to half of 
the lumen improvement with directional coronary atherec-
tomy is due to mechanical stretching. 
Late Results 
Overall results. If defined using a traditional dichotomous 
definition (~50% diameter stenosis at follow-up angiogra-
phy), restenosis was observed in 32% of lesions, similar to 
prior reports (4,27-32). Although the results cannot be 
directly compared with results of conventional angioplasty 
because of differences in reference vessel size or lesion 
location, they may be slightly better than the restenosis rates 
seen with conventional angioplasty (33). The Coronary 
Atherectomy versus Excisional Atherectomy Trial 
(CAVEAT) is now in progress to assess this possibility in 
randomized fashion. 
Lesion location. There was a trend toward a lower inci-
dence of restenosis for lesions in the right coronary artery, 
left circumflex coronary artery or saphenous vein graft than 
for lesions in the left anterior descending artery. To better 
understand the reasons for these findings, the pathobiology 
of restenosis may be broken down into the sum of its 
opposing components: acute gain and late loss (12). Com-
pared with those in the left anterior descending artery, the 
improved late results in the right coronary artery and saphe-
nous vein graft appear to be due to either greater acute gain 
or less late loss. These restenosis data are consistent with 
those of a recent analysis (34) regarding differences in 
restenosis after directional coronary atherectomy and stent-
ing. Although the numbers are small, the encouragingly low 
28% restenosis rate for saphenous vein graft lesions appears 
to be lower than that seen after conventional angioplasty 
(33). This result may be related in part by the higher 
proportion of new lesions (77%) and the large size of the vein 
grafts that we treated, and our observed restenosis rate for 
saphenous vein graft atherectomy is similar to the 25% 
restenosis rate obtained with stenting of vein grafts at our 
institution (19). As expected, our study shows a trend 
supporting prior findings of higher restenosis rates for rest-
enotic lesions (27-32), corresponding to both less acute gain 
and greater late loss than that seen in new lesions. 
Predictors of restenosis. Prior studies (27-32,35) of resten-
osis rates after directional coronary atherectomy have iden-
tified unfavorable late outcomes in lesions that had prior 
restenosis, ostial or saphenous vein graft location, length 
~ 10 mm or percent stenosis < - 10% after atherectomy. In 
our study, however, predictors of unfavorable late results 
after atherectomy included a smaller «3 mm) postatherec-
tomy lumen diameter, a cholesterol level >200 mg/dl and 
absence of recent myocardial infarction. The significantly 
lower restenosis rate when the postatherectomy diameter 
was >3 mm (Fig. 1) reflects the importance of the acute gain: 
the larger the postatherectomy diameter, the less likely it is 
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that subsequent late loss from intimal hyperplasia will com-
promise the overall result (12). Although directional coro-
nary atherectomy as such may stimulate more late loss 
(average I mm) than that seen after conventional balloon 
angioplasty (average 0.4 mm), the greater acute gain with 
atherectomy in larger vessels seems to be sufficient to 
accommodate that increase (12). Although directional coro-
nary atherectomy can reliably and safely achieve such acute 
gain, attempts to obtain similar acute gain by conventional 
angioplasty with oversized balloons unacceptably increases 
the risk of dissection and abrupt vessel closure (36). How-
ever, this advantage of atherectomy may not carry over to 
smaller vessels in which small postatherectomy lumen diam-
eters are less able to offset the late loss due to hyperplasia. 
This hypothesis may explain the higher restenosis rates that 
we observed in vessels whose postatherectomy lumen diam-
eter was <3 mm. 
Cholesterol level obtained at the time of the procedure 
was also found to be a significant predictor of restenosis, 
with a restenosis rate of 40% for a serum cholesterol level 
>200 mg/dl versus 18% for a level :5200 mg/dl (Fig. 2). Our 
study shows that this result is not due to a smaller reference 
vessel or a smaller postatherectomy lumen size in hyper-
cholesterolemic patients. Rather, there appears to be more 
late loss after directional coronary atherectomy in patients 
whose cholesterol level is >200 mg/dl at the time of the 
procedure. Because restenosis after atherectomy is known 
to be due to intimal hyperplasia rather than to accelerated 
atherosclerosis (4), the link between a high cholesterol level 
and greater intimal hyperplasia is unclear. Preliminary stud-
ies (37) in humans suggest that lowering cholesterol with 
lovastatin may reduce the incidence of restenosis, but given 
the contradictory data (38,39) relating cholesterol levels to 
restenosis after conventional angioplasty, a prospective 
study of the effects of cholesterol on restenosis appears 
warranted. 
The mechanism by which a recent myocardial infarction 
is associated with a lower rate of restenosis after directional 
coronary atherectomy is unclear, but there is probably a 
greater thrombus burden in these lesions. Smaller underlying 
plaque mass would increase the rate of acute procedural 
success (9,40) and possibly allow for a larger postatherec-
tomy lumen diameter, yielding a lower rate of restenosis. 
Clinical follow-up. Analysis of our long-term clinical fol-
low-up data shows that the majority. of adverse events 
occurred within the 1st 6 months after directional coronary 
atherectomy, and consisted mainly of repeat revasculariza-
tion procedures (17% of patients underwent coronary angio-
plasty and 12% underwent coronary artery bypass grafting), 
including those performed for other than the atherectomy-
treated lesion. Event-free survival curves then appear to 
level off between 6 and 12 months with an increase in late 
deaths (5%lyear) and ongoing repeat events (7%lyear) during 
the 2nd and 3rd years after the procedure. These late events 
probably represent the underlying natural history of patients 
with complex coronary artery disease because late problems 
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with the atherectomy-treated segment remained rare. Al-
though a direct comparison is difficult because of the high 
(49%) incidence of multivessel disease in our patients who 
underwent directional coronary atherectomy, the overall 
survival and event-free survival rates compare favorably 
with those reported in similar patients after conventional 
angioplasty (41). 
Histologic findings. Deep wall components (medial 
adventitia) continue to be retrieved from a significant per-
cent of lesions without either acute clinical sequelae 
(4,42,43) or an increase in the incidence of subsequent 
restenosis. In fact, we saw a trend toward a lower incidence 
of restenosis when adventitia was retrieved, suggesting that 
the beneficial effect of larger posttreatment lumen appears to 
overshadow any adverse effect that exposure of media and 
adventitia might provide as a stimulus for greater platelet 
deposition or aggregation and subsequent smooth muscle 
cell proliferation. That larger posttreatment lumen diameter 
is probablY partially due to the weakening of the vessel wall 
and local expansion (26). This view is consistent with our 
prior studies (4,42) but at variance with one other study (44). 
However, recent analysis of a combined patient series from 
the Beth Israel and Sequoia Hospitals confirm our single-
center finding that the recovery of deep wall components 
does not predict subsequent restenosis (45). Nevertheless, 
we urge caution in interpretation of these results. Although 
our data should allay the concern that there is an increased 
risk of restenosis when media or adventitia is retrieved, we 
certainly do not recommend that obtaining adventitia should 
be a goal of the procedure. Rather, one should perform 
sufficient cuts directed toward the atherosclerotic plaque to 
obtain optimal angiographic results. Using this approach, we 
have not seen an increased incidence of acute vessel perfo-
ration or late coronary aneurysm formation. 
Limitations of the study. There are several important 
limitations of this study: 1) It is a nonrandomized observa-
tional study in patients whose coronary artery anatomy was 
selected as being suitable for directional coronary atherec-
tomy. Therefore, we cannot make any comparison between 
our results and those of conventional angioplasty. The 
CA VEAT randomized trial of directional coronary atherec-
to my versus conventional balloon angioplasty is currently 
underway to permit such comparison. 2) Angiographic fol-
low-up was incomplete (77% of patients). Although we 
cannot accurately predict what the restenosis rate would 
have been with more complete follow-up, it probably would 
have been lower because of further dilution of the number of 
patients with restenosis (who tend to be studied before 6 
months because of recurrent symptoms) by additional 
asymptomatic patients (without restenosis). 3) The choles-
terol levels that correlate with increased restenosis were 
drawn at the time of the procedure, under various medical 
regimens and clinical conditions, including recent myocar-
dial infarction and unstable angina, that may have altered the 
absolute cholesterol values. Confirmation of our data with 
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serial cholesterol measurements in a larger series of patients 
would be appropriate. 
Conclusions. Our 3-year experience with directional cor-
onary atherectomy in 225 lesions suggests that the procedure 
can be performed with excellent success and safety in a 
group that represents at least 9% of current interventions. 
We recommend that it be performed so as to achieve the 
largest possible posttreatment lumen diameter within the 
constraints of the reference vessel size and avoidance of 
vessel perforation, but without concern that retrieval of deep 
wall components (media or adventitia) will increase in the 
risk of restenosis. Aggressive attempts to lower serum 
cholesterol levels may also be warranted after the proce-
dure. 
We wish to thank the technical and nursing staffs of our cardiac catheteriza· 
tion laboratory, step-down unit and critical care unit for their continued 
patience, care and skill in managing these patients. 
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